Header Logo

Kimberly Lenz

Concepts (83)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
371
0.650
 Why?
Analgesics, Opioid
4
2019
528
0.550
 Why?
Pain
3
2019
400
0.550
 Why?
Medication Therapy Management
3
2018
18
0.370
 Why?
Antiviral Agents
3
2018
326
0.310
 Why?
Practice Patterns, Physicians'
5
2019
708
0.300
 Why?
Hepatitis C
2
2016
144
0.210
 Why?
United States
10
2019
8123
0.160
 Why?
Drug Utilization Review
2
2017
50
0.150
 Why?
Chloride Channel Agonists
1
2019
2
0.150
 Why?
Aminophenols
1
2019
3
0.150
 Why?
Drug and Narcotic Control
2
2017
27
0.150
 Why?
Benzodioxoles
1
2019
11
0.150
 Why?
Aminopyridines
1
2019
34
0.150
 Why?
Quinolones
1
2019
25
0.150
 Why?
Uridine Monophosphate
1
2018
8
0.140
 Why?
Fluorenes
1
2018
13
0.140
 Why?
Cystic Fibrosis
1
2019
126
0.140
 Why?
Benzimidazoles
1
2018
55
0.130
 Why?
Psychotropic Drugs
1
2018
81
0.130
 Why?
Insurance, Pharmaceutical Services
2
2014
17
0.130
 Why?
Hydrocodone
1
2017
6
0.130
 Why?
Hepatitis C, Chronic
1
2018
89
0.130
 Why?
Hepacivirus
1
2018
133
0.130
 Why?
Drug Prescriptions
1
2018
165
0.130
 Why?
Progesterone
1
2017
165
0.120
 Why?
Opioid-Related Disorders
2
2014
528
0.120
 Why?
Medication Adherence
1
2017
202
0.120
 Why?
Premature Birth
1
2017
116
0.120
 Why?
Prescription Drug Diversion
1
2014
6
0.110
 Why?
Lung
1
2019
969
0.100
 Why?
Prescription Drug Misuse
1
2014
20
0.100
 Why?
State Government
1
2014
32
0.100
 Why?
Drug Combinations
3
2019
166
0.100
 Why?
Drug Interactions
1
2014
125
0.100
 Why?
Managed Care Programs
1
2014
86
0.100
 Why?
Retrospective Studies
7
2018
6934
0.090
 Why?
Health Services Accessibility
1
2016
595
0.080
 Why?
Mental Disorders
1
2018
820
0.080
 Why?
Treatment Outcome
3
2016
5808
0.070
 Why?
Young Adult
4
2019
4827
0.070
 Why?
Adolescent
4
2019
6327
0.070
 Why?
Adult
6
2019
17435
0.060
 Why?
Humans
10
2019
65385
0.060
 Why?
Drug Costs
2
2016
55
0.060
 Why?
Cost Savings
2
2016
60
0.050
 Why?
Cost-Benefit Analysis
2
2017
318
0.050
 Why?
Program Evaluation
2
2018
498
0.050
 Why?
Female
7
2019
34146
0.050
 Why?
Pharmacists
2
2016
131
0.050
 Why?
Middle Aged
5
2019
18357
0.050
 Why?
Male
6
2019
31147
0.050
 Why?
Massachusetts
2
2018
2149
0.040
 Why?
Cohort Studies
2
2017
2631
0.040
 Why?
Child
2
2019
4608
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
81
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Sofosbuvir
1
2018
16
0.030
 Why?
Ribavirin
1
2018
22
0.030
 Why?
Polypharmacy
1
2018
67
0.030
 Why?
Treatment Failure
1
2018
208
0.030
 Why?
Hydroxyprogesterones
1
2017
5
0.030
 Why?
Controlled Substances
1
2017
4
0.030
 Why?
Viral Load
1
2018
230
0.030
 Why?
RNA, Viral
1
2018
266
0.030
 Why?
Drug Therapy, Combination
1
2018
463
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
857
0.030
 Why?
Gestational Age
1
2017
194
0.030
 Why?
Psychiatry
1
2018
128
0.030
 Why?
Genotype
1
2018
674
0.030
 Why?
Evidence-Based Medicine
1
2018
463
0.030
 Why?
Insurance Claim Review
1
2016
76
0.030
 Why?
Pregnancy Outcome
1
2017
202
0.030
 Why?
Drug Monitoring
1
2016
203
0.030
 Why?
Government Regulation
1
2014
39
0.030
 Why?
Interdisciplinary Communication
1
2014
106
0.020
 Why?
Physician's Role
1
2014
122
0.020
 Why?
Cooperative Behavior
1
2014
230
0.020
 Why?
Health Policy
1
2014
191
0.020
 Why?
Mutation
1
2019
2665
0.020
 Why?
Pregnancy
1
2017
2392
0.020
 Why?
Time Factors
1
2014
3771
0.020
 Why?
Aged
1
2018
15041
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (83)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_